author-placeholder

Mr Chris Fotinopoulos

Chris is a Melbourne writer and ethicist. His work has been published by The New York Times, The Guardian, The Age, The Drum, Crikey, The Huffington Post and The Herald Sun.

More from this expert

Videos iconVideos

In this Product Explainer, Infectious Diseases Physician and Clinical Virologist Prof Tony Cunningham AO provides an overview of the recombinant (ie non-live) Herpes Zoster vaccine including recent advances, efficacy and community effectiveness (7 mins).

Videos iconVideos

An important vaccine for Herpes Zoster prevention is available in Australia. Prof Cunningham AO will describe in practical detail the evidence for its effectiveness, safety profile, indications and contraindications and what advantages it has over other available options. (6 mins)

Monographs iconMonographs

This article discusses herpes zoster, the condition and its complications as well as the benefits, risks and challenges associated with the herpes zoster vaccine.

This article discusses herpes zoster, the condition and its complications as well as the benefits, risks and challenges associated with the herpes zoster vaccine.

Monographs iconMonographs

New and important vaccine for Herpes Zoster prevention is now available in Australia.

Podcasts iconPodcasts

An important vaccine for Herpes Zoster prevention is available in Australia. Prof Cunningham AO will describe in practical detail the evidence for its effectiveness, safety profile, indications and contraindications and what advantages it has over other available options. (6 mins)

Videos iconVideos

Prof Tony Cunningham AO outlines all the latest evidence and information in relation to shingles

Podcasts iconPodcasts

In this Product Explainer, Prof Tony Cunningham AO will provide an update on the recombinant (ie non-live) Herpes Zoster vaccine including a practical explanation of which patients satisfy the “immunocompromised” criteria (7 mins).

Videos iconVideos

Which immunocompromised patients should be given the recombinant (Shingrix) vs the inactivated (Zostavax)- different approaches to vaccination choice.

Podcasts iconPodcasts

In this Product Explainer, Infectious Diseases Physician and Clinical Virologist Prof Tony Cunningham AO provides an overview of the recombinant (ie non-live) Herpes Zoster vaccine including recent advances, efficacy and community effectiveness (7 mins).

Videos iconVideos

Upcoming Healthed Webcast

Tune in for "Gallbladder – When surgery is or is not needed" lecture

Tuesday 26th May, 7pm - 9pm AEST

Speaker

Dr David Yeo

Specialist Upper GI, Hepatobiliary and Bariatric Surgeon; Chris O’Brien Lifehouse, RPA and St George Hospitals

In this talk, surgeon, Dr David Yeo will answer these and many other real-world questions related to this common condition and provide an update on the latest recommendations for the assessment, investigation and management of gallbladder disease.